Advertisement
Advertisement
U.S. Markets close in 3 hrs 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.94-0.16 (-2.25%)
As of 12:16PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.10
Open7.08
Bid6.95 x 800
Ask6.97 x 1400
Day's Range6.85 - 7.08
52 Week Range4.31 - 18.55
Volume97,530
Avg. Volume655,708
Market Cap475.39M
Beta (5Y Monthly)0.26
PE Ratio (TTM)N/A
EPS (TTM)-0.95
Earnings DateMar 15, 2023 - Mar 20, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.75
  • Simply Wall St.

    A Kezar Life Sciences, Inc. (NASDAQ:KZR) insider increased their holdings by 9.9% last year

    Insiders were net buyers of Kezar Life Sciences, Inc.'s ( NASDAQ:KZR ) stock during the past year. That is, insiders...

  • Business Wire

    Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif., January 13, 2023--Kezar Life Sciences, Inc., (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company’s Board of Directors granted two employees nonqualified stock options to purchase 65,000 shares of its common stock with an exercise price of $6.84 per share, which is equal to the closing price of Kezar’s common

  • Business Wire

    Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., January 04, 2023--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that John Fowler, Co-founder and Chief Executive Officer, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 2:15 pm PT in San Francisco, CA.

Advertisement
Advertisement